title: Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis.
abstract: The fibroblast growth factor (FGF) regulates a broad spectrum of biological activities by activation of transmembrane FGF receptor (FGFR) tyrosine kinases and their coupled intracellular signaling pathways. FGF receptor substrate 2alpha (FRS2alpha) is an FGFR interactive adaptor protein that links multiple signaling pathways to the activated FGFR kinase. We previously showed that FGFR2 in the prostate epithelium is important for branching morphogenesis and for the acquisition of the androgen responsiveness. Here we show in mice that FRS2alpha is uniformly expressed in the epithelial cells of developing prostates, whereas it is expressed only in basal cells of the mature prostate epithelium. However, expression of FRS2alpha was apparent in luminal epithelial cells of regenerating prostates and prostate tumors. To investigate FRS2alpha function in the prostate, the Frs2alpha alleles were ablated specifically in the prostatic epithelial precursor cells during prostate development. Similar to the ablation of Fgfr2, ablation of Frs2alpha disrupted MAP kinase activation, impaired prostatic ductal branching morphogenesis and compromised cell proliferation. Unlike the Fgfr2 ablation, disrupting Frs2alpha had no effect on the response of the prostate to androgens. More importantly, ablation of Frs2alpha inhibited prostatic tumorigenesis induced by oncogenic viral proteins. The results suggest that FRS2alpha-mediated signals in prostate epithelial cells promote branching morphogenesis and proliferation, and that aberrant activation of FRS2-linked pathways might promote tumorigenesis. Thus, the prostate-specific Frs2alpha(cn) mice provide a useful animal model for scrutinizing the molecular mechanisms underlying prostatic development and tumorigenesis.
authors.affiliation: Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, 2121 W. Holcombe Blvd., Houston, TX 77030-3303, USA.
authors.forename: Yongyou
authors.initials: Y
authors.lastname: Zhang
authors.forename: Jue
authors.initials: J
authors.lastname: Zhang
authors.forename: Yongshun
authors.initials: Y
authors.lastname: Lin
authors.forename: Yongsheng
authors.initials: Y
authors.lastname: Lan
authors.forename: Chunhong
authors.initials: C
authors.lastname: Lin
authors.forename: Jim W
authors.initials: JW
authors.lastname: Xuan
authors.forename: Michael M
authors.initials: MM
authors.lastname: Shen
authors.forename: Wallace L
authors.initials: WL
authors.lastname: McKeehan
authors.forename: Norman M
authors.initials: NM
authors.lastname: Greenberg
authors.forename: Fen
authors.initials: F
authors.lastname: Wang
mesh_terms: D000483:Alleles; D000728:Androgens / Q000494:pharmacology; D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D004848:Epithelium / Q000378:metabolism / Q000473:pathology; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009928:Organ Specificity / Q000187:drug effects; D038081:Organogenesis; D011467:Prostate / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000473:pathology*; D012038:Regeneration / Q000187:drug effects; D012741:Sexual Maturation / Q000187:drug effects
chemical_list: D000728:Androgens; C488187:FRS2alpha protein, mouse; D008565:Membrane Proteins; D020928:Mitogen-Activated Protein Kinases